<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:usg="https://explorer.usaid.gov">
  <iati-identifier>US-GOV-1-72065620C00003</iati-identifier>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="PT">Cuidado e apoio adultos</narrative>
   <narrative xml:lang="EN">Treatment/Adult Treatment</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">All facility-based and home/community-based activities for HIV-infected adults and their families aimed at extending and optimizing quality of life for HIV-infected clients and their families throughout the continuum of illness through provision of clinical, psychological, spiritual, social and prevention services. Clinical care should include prevention and treatment of OIs (excluding TB) and other HIV/AIDS-related complications including malaria and diarrhea (providing access to commodities such as pharmaceuticals, insecticide-treated nets, safe water interventions and related laboratory services), pain and symptom relief, and nutritional assessment and support including food. Psychological and spiritual support may include group and individual counseling and culturally-appropriate end-of-life care and bereavement services. Social support may include vocational training, income-generating activities, social and legal protection, and training and support of caregivers. Prevention services may include prevention for positives behavioral counseling, and counseling and testing of family members. The purchase of OI drugs (excluding TB drugs) should be included under Adult Care and Treatment. ARV treatment should be coded under Adult Treatment and ARV Drugs.</narrative>
   <narrative xml:lang="PT">Todo o facilidade-baseado e em casa/atividades comunidade-baseadas para adultos VIH-contaminados e seu alargamento visado fam&#xED;lias e aperfei&#xE7;oamento da qualidade de vida para clientes VIH-contaminados e suas fam&#xED;lias durante todo a s&#xE9;rie cont&#xED;nua de doen&#xE7;a atrav&#xE9;s da disposi&#xE7;&#xE3;o de servi&#xE7;os cl&#xED;nicos, psicol&#xF3;gicos, espirituais, sociais e da preven&#xE7;&#xE3;o. O cuidado cl&#xED;nico deve incluir a preven&#xE7;&#xE3;o e o tratamento de OIs (com exclus&#xE3;o da TB) e as outras complica&#xE7;&#xF5;es de HIV/AIDS-related que incluem a mal&#xE1;ria e a diarreia (que fornecem o acesso &#xE0;s mercadorias tais como f&#xE1;rmacos, redes inseticida-tratadas, interven&#xE7;&#xF5;es seguras da &#xE1;gua e servi&#xE7;os de laborat&#xF3;rio relativos), o relevo da dor e do sintoma, e avalia&#xE7;&#xE3;o nutritiva e apoio que incluem o alimento. O apoio psicol&#xF3;gico e espiritual pode incluir o grupo e assist&#xEA;ncia individual e servi&#xE7;os culturalmente-apropriados do cuidado e do falecimento da fim--vida. O apoio social pode incluir a forma&#xE7;&#xE3;o vocacional, renda-gerando atividades, social e prote&#xE7;&#xE3;o legal, e treinamento e apoio dos cuidadors. Os servi&#xE7;os da preven&#xE7;&#xE3;o podem incluir a preven&#xE7;&#xE3;o para a assist&#xEA;ncia comport&#xE1;vel dos positivos, e a assist&#xEA;ncia e o teste de membros da fam&#xED;lia. A compra de drogas de OI (com exclus&#xE3;o das drogas da TB) deve ser inclu&#xED;da sob o cuidado e o tratamento adultos. O tratamento de ARV deve ser codificado sob o tratamento adulto e as drogas de ARV.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">CONSULMAR PROJECTISTAS E CONSULTORES</narrative>
  </participating-org>
  <participating-org ref="US-GOV-11" role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-10-01" type="1"></activity-date>
  <activity-date iso-date="2020-10-01" type="2"></activity-date>
  <activity-date iso-date="2021-09-30" type="3"></activity-date>
  <activity-date iso-date="2021-09-30" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN"></narrative>
   </person-name>
   <telephone>+1 (202) 712 4810</telephone>
   <email>aidtransparency@usaid.gov</email>
   <website>https://www.usaid.gov/mozambique</website>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction ref="8C4B440F9364">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="USD" value-date="2020-03-31">199602</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="AE220B4F4E37">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2020-06-30">19499</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="3CF603DAE2A4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">89819.08</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="5FB170E7DD7D">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">20398</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="E8FB5A5B223C">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">54602</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2019" end="2023"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="B51CB88DED2C">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">90283.52</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="AFAA2576A2B6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">40502.68</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="MZ"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2019" end="2023"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <conditions attached="0"></conditions>
  <usg:duns-number>
   <narrative>561237604</narrative>
  </usg:duns-number>
  <usg:mechanism-signing-date iso-date="2020-10-01"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Mozambique</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>274602.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
